Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Prostate Cancer Metastatic


Prostate Cancer


CRPC
RECRUITING
NCT04686305
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
304 Enrollment(s)
91 Study location(s)
INTERVENTIONAL (PHASE1)
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT05034887
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients With HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
64 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Adenocarcinoma


Gastroesophageal Junction Adenocarcinoma
COMPLETED
NCT00117494
Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)
86 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Hyperlipidemia


HIV Infections
RECRUITING
NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
39 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (PHASE2)
Salivary Gland Carcinoma


Precision Therapy
TERMINATED
NCT05744375
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
2 Enrollment(s)
19 Study location(s)
INTERVENTIONAL (PHASE2)
Locally Advanced Breast Cancer


Metastatic Breast Cancer
RECRUITING
NCT06740799
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
12 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE1)
Hepatic Impairment
ACTIVE_NOT_RECRUITING
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
65 Enrollment(s)
27 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia